Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Recalls & Warnings February 06, 2015 POM Wonderful Claims Were Deceptive, Court Rules On January 30, 2015, the Federal Trade Commission (FTC) announced that an appeals court has upheld the Commission's ruling that marketers for POM Wonderful made deceptive health claims about the product
Researchers and clinicians should consider the specific tissue target, desired route of administration, and available evidence base when evaluating these peptides
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists
Pregnancy is a time of constant change
You can read the abstract of this article at In this study, the researchers compared the effects of tirzepatide, a novel treatment for type 2 diabetes, with insulin degludec using continuous glucose monitoring (CGM)
